L. Juhlin, C. Arendt
Jul 1, 1988
Citations
1
Influential Citations
68
Citations
Quality indicators
Journal
British Journal of Dermatology
Abstract
The efficacy of cetirizine dihydrochloride, a new H1‐antagonist with minimal sedative or anticholinergic side effects was evaluated in 30 patients with chronic idiopathic urticaria. In the first part of the study, cetirizine 10 mg and placebo were compared in a double‐blind cross‐over trial. In the second part, patients who did not respond adequately in the first part were randomized, still double‐blind, to receive 10 mg cetirizine either once daily or twice daily.